e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Allergen immunotherapy and anti-immunoglobulin E
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sublinguial allergen extract immunotherapy in a rush pattern to reach the maintainance faster
N. Pandey, S. Kole, S. P. Singh, S. Gupta Bhattacharya, S. Kumar, S. Bibhore (Kolkata, Purnia, Kol, Panchkulla, India)
Source:
Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Session:
Allergen immunotherapy and anti-immunoglobulin E
Session type:
Poster Discussion
Number:
262
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Pandey, S. Kole, S. P. Singh, S. Gupta Bhattacharya, S. Kumar, S. Bibhore (Kolkata, Purnia, Kol, Panchkulla, India). Sublinguial allergen extract immunotherapy in a rush pattern to reach the maintainance faster. Eur Respir J 2011; 38: Suppl. 55, 262
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Specific immunotherapy with high dose grass allergen tablets was safe in grass pollen induced asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 134s
Year: 2005
Bronchial challenge with flour: early response is dependent on the dose of activated allergen inhaled
Source: Eur Respir J 2002; 20: 409-416
Year: 2002
Sublingual allergen specific immunotherapy in children with respiratory allergies – long lasting efficacy
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Mild asthmatic patients consistently respond to natural, low dose, allergen challenge in an EEC
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
Reduced late asthmatic response by repeated low-dose allergen exposure
Source: Eur Respir J 2001; 17: 872-880
Year: 2001
Specific allergen immunotherapy might be safer than previous assumed when performed correct
Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Year: 2007
Effects of 3-yr immunotherapy with standardised extracts of house dust mite in allergic asthmatic subjects receiving appropriate drug treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 107s
Year: 2002
Allergen specific immunotherapy efficacy in children with pollen-food allergy syndrome and different IgE profiles to recombinant component-resolved allergens.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Effect of allergen-specific immunotherapy on platelet secretory activity in patients with house-dust mite allergy
Source: Eur Respir J 2007; 30: Suppl. 51, 369s
Year: 2007
Effect of allergen particle size on inflammatory and cellular profile after mite bronchial challenge test
Source: Eur Respir J 2006; 28: Suppl. 50, 593s
Year: 2006
Evaluation and efficacy of allergen immunotherapy in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 399s
Year: 2005
The inhaled allergen challenge test
Source: Short video discussion 2022
Year: 2022
Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
The immune characteristics of inhalational tolerance induced by prolonged allergen exposure
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Optimum dosing regimen for repeated low dose allergen challenge in chronic allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 103s
Year: 2001
Evaluation of nasal response to birch allergen in ALYATEC EEC as compared to NPT
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
Investigation of gene expression in relation to omalizumab treatment and peanut oral immunotherapy
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020
Identification of late asthmatic reactions following specific inhalation challenge
Source: International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept